组蛋白脱乙酰基酶抑制剂抗肿瘤机制及其临床意义的研究进展
被引量:3
出处
《肝胆外科杂志》
2010年第1期66-69,共4页
Journal of Hepatobiliary Surgery
基金
安徽省教育厅自然科学研究项目(KJ2008B066)
参考文献43
-
1Huang C, Sloan EA, Boerkoel CF. Chromatin remodeling and human disease. Curr Opin Genet Dev,2003,13 ( 3 ) :246 - 252.
-
2Khochbin S, Verdel A, Lemercier C, et al. Fuaetional significance af histone deacetylase diversity. Curr Opin Genet Dev,2001,11 (2) : 162 - 166.
-
3Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed eelis. J Natl Cancer Inst,2000,92( 15 ) : 1210 - 1216.
-
4Monneret C. Histone deacetylase inhibitors. Eur J Med Chem,2005, 40(1):1 -13.
-
5Gray SG,Qian CN,Furge K,et al. Microarmy profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. Int J Oncol,2004,24(4) :773 -795.
-
6Peart MJ,Smyth GK,van Laar RK,et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci USA,2005,102(10) :3697 - 3702.
-
7Rascle A, Johnston JA, Amati B. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STATS. Mol Cell Biol,2003,23(12) :4162 -4173.
-
8Archer SY, Meng S, Shei A, et al. p21 (WAF1) is required for buryrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA, 1998,95 ( 12 ) :6791 - 6796.
-
9Ouwehand K, de Ruijter A J, van Bree C, et al. Histone deacetylase inhibitor BL1521 induces a Gl-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. FEBS Lett,2005,579 (6) :1523 - 1528.
-
10Fang JY. Histone deaeetylase inhibitors, antieaneerous mechanism and therapy for gastrointestinal cancers. J Gastroenterol Hepatol, 2005,20 (7) :988 - 994.
同被引文献82
-
1李晓晖,李建勋,李世荣,修志龙,西野宪和.环肽类组蛋白去乙酰化酶抑制剂[J].化学进展,2007,19(5):762-768. 被引量:7
-
2Dokmanovic M,Clarke C,Marks PA.Histone deacetylase in hibitors:overview and perpectives[J].Mol Cancer Res,2007,5(10):981-989.
-
3Vigushin DM,Coombes RC.Histone deacetylase inhibitors in cancer treatment[J].Anticancer Drugs,2002,13(1):1-13.
-
4Witt O,Deubzer HE,Milde T,et al.HDAC family:what are the cancer relevant targets[J]? Cancer Letters,2009,277:8-21.
-
5RosatoRR,Maqqio SC,Almenara JA,et al.The histone deacety-lase inhibitor LAQ824 induces human leukemia cell death thmugha process involving XIAP down-regulation,oxidative injury,and the acid sphingomy-elinase-dependent generation of ceramide[J].Mol Pharmacol,2006,69(1):216-225.
-
6Kim S,Kang JK,Kim YK,et al.Histone deacetylase inhibitor api-cidin induces cyclin E expression through Sp1 sites[J].Biochem Biophys Res Commun,2006,342(4):1168-1173.
-
7Archer SY,Meng S,Shei A,et al.p21(WAF1) is required for buty-rate-mediated growth inhibition of human colon cancer cells[J].Proc Natl Acad Sci USA,1998,95(12):6791-6796.
-
8Ouwehand K,deRuijter AJ,van Bree C,et al.Histone deacetylase in-hibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins[J].FEBS Lett,2005,579(6):1523-1528.
-
9Fang JY.Histone deacetylase inhibitors,anticancerous mechanism and therapy for gastrointestinal cancers[J].J Gastroenterol Hepato,2005,20(7):988-994.
-
10Sakajiri S,Kumagai T,Kawamata N,et al.Histone deacetylase inhibi-tors profoundly decrease proliferation of human lymphoid cancer cell lines[J].Exp Hemato,2005,33(1):53-61.
引证文献3
-
1张倩云,任雯,李潇,祁赞梅.组蛋白乙酰化影响肿瘤细胞多药耐药性的研究进展[J].现代肿瘤医学,2011,19(5):1022-1026. 被引量:2
-
2楼文珠,孙雪燕,李龙珠,宋梦婉,陶晶,郭俊明.组蛋白脱乙酰酶抑制剂的抗癌作用[J].中国细胞生物学学报,2011,33(9):1045-1052. 被引量:7
-
3邓星,苟立平,温倩雯,罗莉娅,万丽.组蛋白去乙酰化酶抑制剂F321-2治疗肿瘤的机制研究[J].中国新药与临床杂志,2018,37(11):640-645. 被引量:1
二级引证文献10
-
1谌贺宽子,梁天祥,仇庆,夏玉龙,吴欣欣,周秀梅.组蛋白去乙酰化酶抑制剂SAHA联合溶瘤腺病毒ZD55-IL-24诱导SW480细胞凋亡[J].中国细胞生物学学报,2012,34(1):54-60. 被引量:4
-
2宋皓军,俞秀冲,夏天,郭俊明,肖丙秀.长链非编码RNA与肿瘤的关系及其临床价值[J].中国细胞生物学学报,2012,34(7):704-712. 被引量:32
-
3郑园园,肖丙秀,乐燕萍,郭俊明.以微小RNA作为新型标志物检测循环肿瘤细胞及其临床意义[J].中国细胞生物学学报,2012,34(9):936-941. 被引量:3
-
4邢静,吴维光,闫红亮,王筝,孙兆翎,唐雅娟.组蛋白去乙酰化酶1siRNA对人宫颈癌SiHa细胞增殖及凋亡的影响[J].现代肿瘤医学,2013,21(11):2413-2416. 被引量:2
-
5龚飞虎,孙丽萍.多重靶向的4-取代苯胺喹唑啉类衍生物抗肿瘤活性研究进展[J].药学进展,2014,38(1):25-30. 被引量:3
-
6宋健,马晓,李荣国,赵悦,张东伟.长链非编码RNA与乳腺癌相关性的研究进展[J].中华实验外科杂志,2015,32(1):217-218. 被引量:2
-
7刘宸畅,徐雪莲,孙延龙,张秀丽,王聪,庄波,范迎方,张广桃,王成.海洋小分子药物临床研究进展[J].中国海洋药物,2015,34(1):73-89. 被引量:12
-
8梅亚君,秦永平,章丽,南峰,向瑾,余勤,梁茂植.高效液相色谱-串联质谱法测定人血清中伏立诺他及其M2代谢物浓度[J].华西医学,2016,31(2):278-282. 被引量:1
-
9徐子君,王沁,梁冰.梁冰教授治疗套细胞淋巴瘤验案2则[J].中医药导报,2017,23(22):54-55. 被引量:2
-
10李佳昕,翟宏菊,孙德武,关壬铨,王岩,齐云峰.伏立诺他复合物及其类似物的抗肿瘤研究进展[J].中国新药与临床杂志,2019,38(6):321-327.
-
1沈文静,郭科军,宋爽,戴冬秋.丁酸钠对卵巢癌细胞系CAOV3的生长抑制作用及机制[J].山东医药,2008,48(1):123-125.
-
2沈文静,戴冬秋,滕玥,刘杰.丁酸钠对胃癌细胞系生长的抑制作用及其机制[J].中国医科大学学报,2007,36(3):247-248. 被引量:1
-
3梁颇,黄旭晴,李万成.组蛋白去乙酰化酶与新生血管形成的关系[J].国际呼吸杂志,2009,29(5):317-320. 被引量:1
-
4史鸿云,李志刚,刘妙玲,祝淑钗,薛桂花,李延红.沉默食管癌ECA109细胞H2AX基因对裸鼠移植瘤放射敏感性的影响[J].中华放射医学与防护杂志,2014,34(11):827-831.
-
5吕琳,吴少瑜,饶进军.组蛋白乙酰转移酶和去乙酰化酶的研究[J].现代医院,2008,8(4):1-6. 被引量:6
-
6李莉,李真,王亚丽.H3K9Ac在卵巢上皮性肿瘤中的表达及其临床意义[J].中国优生与遗传杂志,2007,15(4):33-35.
-
7宋柯琦,狄文.组蛋白脱乙酰基酶及其抑制剂与宫颈癌[J].中国妇幼健康研究,2010,21(1):114-116.
-
8柯颖,曹波,雷志勇,陈虹.组蛋白脱乙酰基酶抑制剂抗癌机理及临床应用的最新进展[J].武警医学院学报,2008,17(6):546-549.
-
9白慧颖,胡森,冀文茹.组蛋白去乙酰化酶抑制剂的研究进展[J].感染.炎症.修复,2009,10(3):187-189. 被引量:3
-
10肖巍魏,韩非,卢泰祥.组蛋白脱乙酰基酶抑制剂对X线照射前列腺癌细胞系放射增敏实验研究[J].中华放射肿瘤学杂志,2011,20(3):250-254.